Selected research
Market Outlook & Growth Opportunities
Global Temazepam Capsule Market Outlook and Growth Opportunities 2026
Market perspective
The global Temazepam Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Temazepam Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Temazepam Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Temazepam Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Temazepam Capsule market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Temazepam Capsule market include Teva, Sun Pharma, Mylan, Mallinckrodt Pharmaceuticals, Major Pharmaceuticals and Ascend Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Temazepam Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Temazepam Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Temazepam Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Temazepam Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.
Temazepam Capsule Segment by Company
Teva
Sun Pharma
Mylan
Mallinckrodt Pharmaceuticals
Major Pharmaceuticals
Ascend Laboratories
Temazepam Capsule Segment by Type
7.5mg
30mg
22.5mg
15mg
Temazepam Capsule Segment by Application
Recovery Center
Hospital
Special Clinic
Temazepam Capsule Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Temazepam Capsule status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Temazepam Capsule market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Temazepam Capsule significant trends, drivers, influence factors in global and regions.
6. To analyze Temazepam Capsule competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Temazepam Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Temazepam Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Temazepam Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Temazepam Capsule market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Temazepam Capsule industry.
Chapter 3: Detailed analysis of Temazepam Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Temazepam Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Temazepam Capsule in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 7.5mg
- 30mg
- 22.5mg
- 15mg
Applications
- Recovery Center
- Hospital
- Special Clinic
Companies covered
- Teva
- Sun Pharma
- Mylan
- Mallinckrodt Pharmaceuticals
- Major Pharmaceuticals
- Ascend Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Temazepam Capsule Sales Value (2021-2032)
- 1.2.2 Global Temazepam Capsule Sales Volume (2021-2032)
- 1.2.3 Global Temazepam Capsule Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Temazepam Capsule Market Dynamics
- 2.1 Temazepam Capsule Industry Trends
- 2.2 Temazepam Capsule Industry Drivers
- 2.3 Temazepam Capsule Industry Opportunities and Challenges
- 2.4 Temazepam Capsule Industry Restraints
3 Temazepam Capsule Market by Company
- 3.1 Global Temazepam Capsule Company Revenue Ranking in 2025
- 3.2 Global Temazepam Capsule Revenue by Company (2021-2026)
- 3.3 Global Temazepam Capsule Sales Volume by Company (2021-2026)
- 3.4 Global Temazepam Capsule Average Price by Company (2021-2026)
- 3.5 Global Temazepam Capsule Company Ranking (2024-2026)
- 3.6 Global Temazepam Capsule Company Manufacturing Base and Headquarters
- 3.7 Global Temazepam Capsule Company Product Type and Application
- 3.8 Global Temazepam Capsule Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Temazepam Capsule Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Temazepam Capsule Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Temazepam Capsule Market by Type
- 4.1 Temazepam Capsule Type Introduction
- 4.1.1 7.5mg
- 4.1.2 30mg
- 4.1.3 22.5mg
- 4.1.4 15mg
- 4.2 Global Temazepam Capsule Sales Volume by Type
- 4.2.1 Global Temazepam Capsule Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Temazepam Capsule Sales Volume by Type (2021-2032)
- 4.2.3 Global Temazepam Capsule Sales Volume Share by Type (2021-2032)
- 4.3 Global Temazepam Capsule Sales Value by Type
- 4.3.1 Global Temazepam Capsule Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Temazepam Capsule Sales Value by Type (2021-2032)
- 4.3.3 Global Temazepam Capsule Sales Value Share by Type (2021-2032)
5 Temazepam Capsule Market by Application
- 5.1 Temazepam Capsule Application Introduction
- 5.1.1 Recovery Center
- 5.1.2 Hospital
- 5.1.3 Special Clinic
- 5.2 Global Temazepam Capsule Sales Volume by Application
- 5.2.1 Global Temazepam Capsule Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Temazepam Capsule Sales Volume by Application (2021-2032)
- 5.2.3 Global Temazepam Capsule Sales Volume Share by Application (2021-2032)
- 5.3 Global Temazepam Capsule Sales Value by Application
- 5.3.1 Global Temazepam Capsule Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Temazepam Capsule Sales Value by Application (2021-2032)
- 5.3.3 Global Temazepam Capsule Sales Value Share by Application (2021-2032)
6 Temazepam Capsule Regional Sales and Value Analysis
- 6.1 Global Temazepam Capsule Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Temazepam Capsule Sales by Region (2021-2032)
- 6.2.1 Global Temazepam Capsule Sales by Region: 2021-2026
- 6.2.2 Global Temazepam Capsule Sales by Region (2027-2032)
- 6.3 Global Temazepam Capsule Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Temazepam Capsule Sales Value by Region (2021-2032)
- 6.4.1 Global Temazepam Capsule Sales Value by Region: 2021-2026
- 6.4.2 Global Temazepam Capsule Sales Value by Region (2027-2032)
- 6.5 Global Temazepam Capsule Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Temazepam Capsule Sales Value (2021-2032)
- 6.6.2 North America Temazepam Capsule Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Temazepam Capsule Sales Value (2021-2032)
- 6.7.2 Europe Temazepam Capsule Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Temazepam Capsule Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Temazepam Capsule Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Temazepam Capsule Sales Value (2021-2032)
- 6.9.2 South America Temazepam Capsule Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Temazepam Capsule Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Temazepam Capsule Sales Value Share by Country, 2025 VS 2032
7 Temazepam Capsule Country-level Sales and Value Analysis
- 7.1 Global Temazepam Capsule Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Temazepam Capsule Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Temazepam Capsule Sales by Country (2021-2032)
- 7.3.1 Global Temazepam Capsule Sales by Country (2021-2026)
- 7.3.2 Global Temazepam Capsule Sales by Country (2027-2032)
- 7.4 Global Temazepam Capsule Sales Value by Country (2021-2032)
- 7.4.1 Global Temazepam Capsule Sales Value by Country (2021-2026)
- 7.4.2 Global Temazepam Capsule Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.9.2 France Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.16.2 China Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.19.2 India Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Temazepam Capsule Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Temazepam Capsule Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Temazepam Capsule Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Temazepam Capsule Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Teva Temazepam Capsule Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Sun Pharma
- 8.2.1 Sun Pharma Company Information
- 8.2.2 Sun Pharma Business Overview
- 8.2.3 Sun Pharma Temazepam Capsule Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Sun Pharma Temazepam Capsule Product Portfolio
- 8.2.5 Sun Pharma Recent Developments
- 8.3 Mylan
- 8.3.1 Mylan Company Information
- 8.3.2 Mylan Business Overview
- 8.3.3 Mylan Temazepam Capsule Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Mylan Temazepam Capsule Product Portfolio
- 8.3.5 Mylan Recent Developments
- 8.4 Mallinckrodt Pharmaceuticals
- 8.4.1 Mallinckrodt Pharmaceuticals Company Information
- 8.4.2 Mallinckrodt Pharmaceuticals Business Overview
- 8.4.3 Mallinckrodt Pharmaceuticals Temazepam Capsule Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Mallinckrodt Pharmaceuticals Temazepam Capsule Product Portfolio
- 8.4.5 Mallinckrodt Pharmaceuticals Recent Developments
- 8.5 Major Pharmaceuticals
- 8.5.1 Major Pharmaceuticals Company Information
- 8.5.2 Major Pharmaceuticals Business Overview
- 8.5.3 Major Pharmaceuticals Temazepam Capsule Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Major Pharmaceuticals Temazepam Capsule Product Portfolio
- 8.5.5 Major Pharmaceuticals Recent Developments
- 8.6 Ascend Laboratories
- 8.6.1 Ascend Laboratories Company Information
- 8.6.2 Ascend Laboratories Business Overview
- 8.6.3 Ascend Laboratories Temazepam Capsule Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Ascend Laboratories Temazepam Capsule Product Portfolio
- 8.6.5 Ascend Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Temazepam Capsule Value Chain Analysis
- 9.1.1 Temazepam Capsule Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Temazepam Capsule Sales Mode & Process
- 9.2 Temazepam Capsule Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Temazepam Capsule Distributors
- 9.2.3 Temazepam Capsule Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst